Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure
Biomolecules · 22.02.2023 · 13 (3) · 410
DOI: 10.3390/biom13030410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 22.02.2023. Verfasst von Elles M Screever und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. Hauptthemen laut MEDLINE: Cardiomyopathies, Heart Failure. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Heart Foundation, University Medical Center Groningen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Ongoing adverse remodeling is a hallmark of heart failure (HF), which might be reflected by either focal or diffuse myocardial fibrosis. Therefore, in (pre)clinical settings, we used immunohistochemistry or cardiac magnetic resonance imaging (CMR) to investigate the association of (focal or diffuse) fibrosis with cardiac biomarkers and adverse events in HF. Methods and results: In C57Bl/6J mice, we determined the presence and extent of myocardial fibrosis 6 weeks post-myocardial infarction (MI). Furthermore, we studied 159 outpatient HF patients who underwent CMR, and determined focal and diffuse fibrosis by late gadolinium enhancement (LGE) and post-contrast T1 time of the non-LGE myocardium, respectively. HF patients were categorized based on the presence of LGE, and by the median post-contrast T1 time. Kaplan–Meier and Cox regression analyses were used to determine the association of fibrosis with HF hospitalization and all-cause mortality. LGE was detected in 61 (38%) patients. Cardiac biomarker levels were comparable between LGE-positive and LGE-negative patients. LGE-positive patients with a short T1 time had elevated levels of both NT-proBNP and galectin-3 (1611 vs. 453 ng/L, p = 0.026 and 20 vs. 15 μg/L, p = 0.004, respectively). This was not observed in LGE-negative patients. Furthermore, a short T1 time in LGE-positive patients was associated with a higher risk of adverse events (log-rank p = 0.01).
Conclusion
This study implies that cardiac biomarkers reflect active remodeling of the non-infarcted myocardium of patients with focal myocardial scarring. Diffuse fibrosis, in contrast to focal scarring, might have a higher prognostic value regarding adverse outcomes in HF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
- Department of Cardiology, Thorax Center, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
- Department of Radiology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
ORCID-Profile: Joseph Pierre Aboumsallem, Rudolf A de Boer
Förderung
- Dutch Heart Foundation
- University Medical Center Groningen
Zitieren
APA
Screever, E. M., Gorter, T. M., Willems, T. P., Aboumsallem, J. P., Suthahar, N., Mahmoud, B., van Veldhuisen, D. J., de Boer, R. A., & Meijers, W. C. (2023). Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure. Biomolecules, 13(3), 410. https://doi.org/10.3390/biom13030410
Vancouver
Screever EM, Gorter TM, Willems TP, Aboumsallem JP, Suthahar N, Mahmoud B, et al. Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure. Biomolecules. 2023;13(3):410. doi:10.3390/biom13030410
BibTeX
@article{Screever2023,
author = {Screever, Elles M and Gorter, Thomas M and Willems, Tineke P and Aboumsallem, Joseph Pierre and Suthahar, Navin and Mahmoud, Belend and van Veldhuisen, Dirk J and de Boer, Rudolf A and Meijers, Wouter C},
title = {Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {3},
pages = {410},
doi = {10.3390/biom13030410}
}
EUVIMED